Company: BPAC
Filing Date: 2025-10-22
Form Type: S-1/A
Source: 0001185185-25-001525
Chunk: 139

Company: Blueport Acquisition Ltd
Filing Date: 2025-10-22
Form: S-1/A
Chunk 139
---
 our public shares (or approximately 35.64%) to be voted in favor of the transaction in order
to have such transaction approved (assuming that all issued and outstanding shares are voted, that the over-allotment option is not exercised,
and that the insiders do not purchase any units in this offering or units or shares in the after-market). Assuming that only the holders
of one-third of our issued and outstanding ordinary shares, representing a quorum under our amended and restated memorandum and articles
of association vote their shares at a general meeting of the company, we will not need any public shares in addition to our initial shares
to be voted in favor of an initial business combination in order to approve an initial business combination. Additionally, each public
shareholder may elect to redeem their public shares irrespective of whether they vote for or vote against the proposed transaction, or
whether they do not vote or abstain from voting on the proposed transaction, or whether they were a public shareholder on the record date
for the general meeting held to approve the proposed transaction.

None of our officers, directors,
initial shareholders or their affiliates has indicated any intention to purchase units or ordinary shares in this offering or from persons
in the open market or in private transactions (other than the private units). However, if we hold a meeting to approve a proposed business
combination and a significant number of shareholders vote, or indicate an intention to vote, against such proposed business combination,
our officers, directors, initial shareholders or their affiliates could make such purchases in the open market or in private transactions
in order to influence the vote. Notwithstanding the foregoing, our officers, directors, initial shareholders and their affiliates will
not make purchases of ordinary shares if the purchases would violate Section 9(a)(2) or Rule 10b-5 promulgated under the Exchange Act,
which are rules designed to stop potential manipulation of a company’s share. In addition, our officers, directors, initial shareholders
and their affiliates would structure such purchases to be in compliance with the requirements of Rule 14e-5 under the Exchange Act, including,
in pertinent part, through adherence to the following:

| ● | our registration statement/proxy statement filed for our business combination transaction would disclose the possibility that our sponsor, directors, officers, advisors or their affiliates may purchase shares from public shareholders outside the redemption process, along with the purpose of such purchases; |

| ● | if our sponsor, directors, officers, advisors or their affiliates were to purchase shares from public shareholders, they would